Literature DB >> 21375599

Serotonin innervation of human basal ganglia.

Marie-Josée Wallman1, Dave Gagnon, Martin Parent.   

Abstract

This study aimed to provide a first detailed description of the serotonin (5-hydroxytryptamine, 5-HT) innervation of the human basal ganglia under nonpathological conditions. We applied an immunohistochemical approach to postmortem human brain material with antibodies directed against the 5-HT transporter and the 5-HT-synthesizing enzyme (tryptophane hydroxylase) to visualize 5-HT axons and cell bodies, respectively. Adjacent sections were immunostained for tyrosine hydroxylase to compare the distribution of 5-HT axons with that of dopamine axons. Human basal ganglia are innervated by 5-HT axons that emerge chiefly from the dorsal and, less abundantly, from the median raphe nuclei. These axons form thick ascending fascicles that fragment themselves as they penetrate the decussation of the superior cerebellar peduncle. They regroup within the ventral tegmental area and ascend along the medial forebrain bundle, immediately beneath the dopamine ascending fibers. At regular intervals along their course, 5-HT axons detach themselves from the medial forebrain bundle and sweep laterally to arborize within all basal ganglia components, where they display highly variable densities and patterns of innervation. The substantia nigra is the most densely innervated component of the basal ganglia, whereas the caudate nucleus is more heterogeneously innervated than the putamen and pallidum. The subthalamic nucleus harbors 5-HT-immunoreactive fibers that display a mediolateral-decreasing gradient. The fact that all components of human basal ganglia receive a dense 5-HT input indicates that, in concert with dopamine, 5-HT plays a crucial role in the functional organization of these motor-related structures, which are often targeted in neurodegenerative diseases.
© 2011 The Authors. European Journal of Neuroscience © 2011 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21375599     DOI: 10.1111/j.1460-9568.2011.07621.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  21 in total

Review 1.  Intrinsic and integrative properties of substantia nigra pars reticulata neurons.

Authors:  F-M Zhou; C R Lee
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

Review 2.  Functional connectivity and integrative properties of globus pallidus neurons.

Authors:  D Jaeger; H Kita
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

Review 3.  Neuromodulation for obsessive-compulsive disorder.

Authors:  Kyle A B Lapidus; Emily R Stern; Heather A Berlin; Wayne K Goodman
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 4.  Effects of Subthalamic Nucleus Deep Brain Stimulation on Facial Emotion Recognition in Parkinson's Disease: A Critical Literature Review.

Authors:  S Kalampokini; E Lyros; P Lochner; K Fassbender; M M Unger
Journal:  Behav Neurol       Date:  2020-07-17       Impact factor: 3.342

5.  Immunohistochemical localization of enkephalin in the human striatum: a postmortem ultrastructural study.

Authors:  Lesley A McCollum; Joy K Roche; Rosalinda C Roberts
Journal:  Synapse       Date:  2011-11-18       Impact factor: 2.562

6.  L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease.

Authors:  K L Eskow Jaunarajs; J A George; C Bishop
Journal:  Neuroscience       Date:  2012-06-01       Impact factor: 3.590

7.  Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys.

Authors:  Daniel F Manvich; Heather L Kimmel; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2012-02-10       Impact factor: 4.030

8.  Cocaine increases stimulation-evoked serotonin efflux in the nucleus accumbens.

Authors:  Jason Yuen; Abhinav Goyal; Aaron E Rusheen; Abbas Z Kouzani; Michael Berk; Jee Hyun Kim; Susannah J Tye; Charles D Blaha; Kevin E Bennet; Kendall H Lee; Yoonbae Oh; Hojin Shin
Journal:  J Neurophysiol       Date:  2022-01-05       Impact factor: 2.714

Review 9.  Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.

Authors:  Maria J Ramirez; Mitchell K P Lai; Rosa M Tordera; Paul T Francis
Journal:  Drugs       Date:  2014-05       Impact factor: 9.546

Review 10.  Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?

Authors:  Rick C Helmich; Mark Hallett; Günther Deuschl; Ivan Toni; Bastiaan R Bloem
Journal:  Brain       Date:  2012-03-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.